loadpatents
name:-0.019366979598999
name:-0.016128063201904
name:-0.00046396255493164
Moore; Malcolm A. S. Patent Filings

Moore; Malcolm A. S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moore; Malcolm A. S..The latest application filed is for "methods of treating serosal cancer".

Company Profile
0.15.16
  • Moore; Malcolm A. S. - New York NY US
  • Moore, Malcolm A.S. - Larchmont NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Migrastatin analogs in the treatment of cancer
Grant 8,957,056 - Danishefsky , et al. February 17, 2
2015-02-17
Methods of Treating Serosal Cancer
App 20150030583 - Moore; Malcolm A.S. ;   et al.
2015-01-29
Compounds And Methods For Targeting Leukemic Stem Cells
App 20130338092 - Hartwell; Kimberly ;   et al.
2013-12-19
Catenae: Serosal Cancer Stem Cells
App 20120219506 - Moore; Malcolm A.S. ;   et al.
2012-08-30
Isomigrastatin analogs in the treatment of cancer
Grant 8,188,141 - Danishefsky , et al. May 29, 2
2012-05-29
Cancer treatment by combined inhibition of proteasome and telomerase activities
Grant 7,998,938 - Moore , et al. August 16, 2
2011-08-16
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
Grant 7,875,638 - Danishefsky , et al. January 25, 2
2011-01-25
Cancer treatment by combined inhibition of proteasome and telomerase activities
App 20100010064 - Moore; Malcolm A. S. ;   et al.
2010-01-14
Synthesis of Epothilones, Intermediates Thereto, Analogues and Uses Thereof
App 20090149516 - Danishefsky; Samuel J. ;   et al.
2009-06-11
Migrastatin analogs in the treatment of cancer
App 20090124662 - Danishefsky; Samuel J. ;   et al.
2009-05-14
Isomigrastatin Analogs In The Treatment Of Cancer
App 20090054488 - Danishefsky; Samuel J. ;   et al.
2009-02-26
Ligand for the c-kit receptor and methods of use thereof
App 20080152652 - Besmer; Peter ;   et al.
2008-06-26
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
Grant 7,384,964 - Danishefsky , et al. June 10, 2
2008-06-10
Ligand for the c-kit receptor and methods of use thereof
App 20050276784 - Besmer, Peter ;   et al.
2005-12-15
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
App 20050143429 - Danishefsky, Samuel J. ;   et al.
2005-06-30
Purified populations of stem cells
App 20050142659 - Rafii, Shahin ;   et al.
2005-06-30
Human pluripotent hematopoietic colony stimulating factor, method of production and use
App 20050063946 - Welte, Karl ;   et al.
2005-03-24
Purified populations of stem cells
Grant 6,852,533 - Rafii , et al. February 8, 2
2005-02-08
Human pluripotent hematopoietic colony stimulating factor, method of production and use
Grant 6,838,549 - Welte , et al. January 4, 2
2005-01-04
Ligand for the c-kit receptor and methods of use thereof
App 20030103937 - Besmer, Peter ;   et al.
2003-06-05
Human pluripotent hematopoietic colony stimulating factor, method of production and use
App 20030078197 - Welte, Karl ;   et al.
2003-04-24
C-kit ligand-based method for expanding peripheral blood cell levels
Grant 6,403,559 - Besmer , et al. June 11, 2
2002-06-11
Purified Populations Of Endothelial Progenitor Cells
App 20020051762 - RAFII, SHAHIN ;   et al.
2002-05-02
Use of c-kit ligand with TNF-.alpha. and hematopoietic factors for the expansion or differentiation of hematopoietic cells
Grant 6,159,461 - Besmer , et al. December 12, 2
2000-12-12
Composition of c-kit ligand, GM-CSF, and TNF-.alpha. and method of use
Grant 6,001,803 - Besmer , et al. December 14, 1
1999-12-14
Method for increasing the level of stem cells in peripheral blood
Grant 5,935,565 - Besmer , et al. August 10, 1
1999-08-10
Compositions of soluble C-kit ligand and hematopoietic factors
Grant 5,767,074 - Besmer , et al. June 16, 1
1998-06-16
Pharmacological preparations comprising human pluripotent hematopoietic colony stimulating factor
Grant 5,670,146 - Welte , et al. September 23, 1
1997-09-23
Method of administering human pluripotent hematopoietic colony stimulating factor
Grant 5,662,895 - Welte , et al. September 2, 1
1997-09-02
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed